数位 PCR (dPCR) 和即时PCR(qPCR) 市场规模、份额、成长分析，按技术、按产品、按应用、按最终用户、按地区 - 行业预测，2025-2032 年

2023年，全球数位PCR（dPCR）和即时PCR （qPCR）市场规模为101亿美元，在预测期内（2025-2032年）预计复合年增长率为8.1%，到2024年将达到109.2亿美元。到2032年将从203.6亿美元成长到203.6亿美元。

由于遗传性感染疾病病率的上升以及 PCR 技术的进步，即时PCR和数位 PCR 市场正在显着增长。即时PCR被广泛认为是一种快速、灵敏的定量各种生物样本中核酸的方法。相较之下，数位 PCR 透过将样本分成数千个单独的反应来提供准确的定量，就像 Droplet Digital(TM) PCR 技术中的液滴一样。儘管这些技术对于测量微小的基因突变至关重要，并且可用于各种法医学和实验室应用，但固有的技术限制和疾病检测替代分析的日益使用限制了市场的成长。总体而言，儘管存在这些障碍，dPCR 和 qPCR 市场的未来看起来还是充满希望的。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 监管分析
• 案例研究分析
• 专利分析
• 技术分析

按技术分類的数位 PCR (dPCR) 和即时PCR(qPCR) 市场规模

• 市场概况
• 定量PCR
• 数位PCR

数位 PCR (dPCR) 和即时PCR(qPCR) 市场规模：按产品分类

• 市场概况
• 试剂及耗材
• 装置
• 软体

按应用分類的数位 PCR (dPCR) 和即时PCR(qPCR) 市场规模

• 市场概况
• 临床应用
  • 病原体检测
  • 肿瘤检查
  • 验血
  • 其他临床应用
• 调查申请
• 法医学应用

最终用户的数位 PCR (dPCR) 和即时PCR(qPCR) 市场规模

• 市场概况
• 医院和诊断中心
• 研究实验室和学术机构
• 製药和生物技术公司
• 临床研究组织
• 法医学研究所

数位 PCR (dPCR) 和即时PCR(qPCR) 市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2022-2024）

主要企业简介

• Danaher Corporation（US）
• Bio-Rad Laboratories, Inc.（US）
• Merck KGaA（Germany）
• Becton, Dickinson and Company（US）
• Abbott Laboratories（US）
• Qiagen NV（Germany）
• Thermo Fisher Scientific, Inc.（US）
• F. Hoffmann-La Roche Ltd.（Switzerland）
• Takara Bio, Inc.（Japan）
• Agilent Technologies, Inc.（US）
• GE Healthcare（US）
• bioMerieux（France）
• Fluidigm Corporation（US）
• Roche Diagnostics（Switzerland）
• Illumina, Inc.（US）
• Siemens Healthineers（Germany）
• PerkinElmer, Inc.（US）
• LGC Limited（UK）
• Bio-Techne Corporation（US）
• Cambridge Epigenetix Ltd.（UK）

结论和建议

Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market size was valued at USD 10.1 billion in 2023 and is poised to grow from USD 10.92 billion in 2024 to USD 20.36 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The real-time PCR and digital PCR markets are experiencing significant growth driven by the rising prevalence of genetic and infectious diseases, as well as advancements in PCR technology. Real-time PCR is a widely recognized method for the rapid and sensitive quantification of nucleic acids in diverse biological samples. In contrast, digital PCR offers precise quantification by partitioning samples into thousands of individual reactions, such as droplets in Droplet Digital(TM) PCR technology. While these techniques are integral for measuring minor genetic variants and serve various applications in forensic and research laboratories, market growth may face challenges due to inherent technical limitations and the increasing use of alternative assays for disease detection. Overall, the future of the dPCR and qPCR market appears promising despite these hurdles.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Digital Pcr (Dpcr) And Real-Time Pcr (Qpcr) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Digital Pcr (Dpcr) And Real-Time Pcr (Qpcr) Market Segmental Analysis

Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market is segmented by technology, product, application, end user and region. Based on technology, the market is segmented into quantitative PCR and digital PCR. Based on product, the market is segmented into reagents and consumables, instruments and software. Based on application, the market is segmented into clinical applications, research applications and forensic applications. Based on end user, the market is segmented into hospitals & diagnostic centers, research laboratories & academic institutes, pharmaceutical & biotechnology companies, clinical research organizations & forensic laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Digital Pcr (Dpcr) And Real-Time Pcr (Qpcr) Market

The global digital PCR (dPCR) and real-time PCR (qPCR) market is poised for expansion due to several key drivers. The rising incidence of infectious diseases is expected to significantly enhance the demand for these advanced diagnostic technologies. Additionally, the growing prevalence of genetic disorders highlights the need for precise and efficient testing methods, further fueling market growth. The successful completion of the Human Genome Project has also paved the way for advancements in genetic research and diagnostics, creating a broader application scope for dPCR and qPCR technologies. Collectively, these factors are set to propel the market forward in the coming years.

Restraints in the Global Digital Pcr (Dpcr) And Real-Time Pcr (Qpcr) Market

The global Digital PCR (dPCR) and Real-Time PCR (qPCR) market faces several restraints that could impede its growth during the forecast period. Specific technical challenges inherent in dPCR and qPCR procedures, such as difficulties in accurately measuring signals during the exponential phase of the PCR reaction, as well as the necessity for extensive optimization and validation of assay protocols, can lead to limitations in target detection. These constraints may result in failures when examining target molecules, ultimately affecting the efficiency and reliability of these techniques. Consequently, these technical issues pose significant challenges that may restrict market expansion.

Market Trends of the Global Digital Pcr (Dpcr) And Real-Time Pcr (Qpcr) Market

The Global Digital PCR (dPCR) and Real-Time PCR (qPCR) market is witnessing significant growth, driven largely by rising viral infections and a pressing need for advanced diagnostic solutions. The escalating focus on precision medicine and personalized treatment is propelling the adoption of digital PCR technologies, especially in identifying novel drug targets and biomarkers for viral diseases and rare cancers. Enhanced sensitivity and specificity of digital droplet PCR (ddPCR) are amplifying its utility in tumor profiling and biomarker discovery, thereby attracting increased investment in research and development. This trend underscores a pivotal shift in healthcare innovation aimed at improving patient outcomes through cutting-edge molecular diagnostics.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Case Study Analysis
• Patent Analysis
• Technology Analysis

Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Quantitative PCR
• Digital PCR

Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size by Product & CAGR (2025-2032)

• Market Overview
• Reagents And Consumables
• Instruments
• Software

Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size by Application & CAGR (2025-2032)

• Market Overview
• Clinical Applications
  • Pathogen Testing
  • Oncology Testing
  • Blood Screening
  • Other Clinical Applications
• Research Applications
• Forensic Applications

Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals And Diagnostic Centers
• Research Laboratories & Academic Institutes
• Pharmaceutical & Biotechnology Companies
• Clinical Research Organizations
• Forensic Laboratories

Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size & CAGR (2025-2032)

• North America (Technology, Product, Application, End User)
  • US
  • Canada
• Europe (Technology, Product, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LGC Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cambridge Epigenetix Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations